The debate between semaglutide and tirzepatide dominates the medical weight loss space. Both are injectable peptides that have revolutionized obesity treatment, but they are not the same drug, and they do not work in exactly the same way.
The Core Difference: Single vs. Dual Agonist
Semaglutide is a GLP-1 Receptor Agonist. It mimics a single hormone: Glucagon-Like Peptide-1. It works by binding to receptors in the brain to reduce appetite and in the gut to slow gastric emptying.
Tirzepatide is a Dual Agonist (GLP-1 and GIP). It mimics two hormones. While the GLP-1 component suppresses appetite, the addition of GIP improves how the body breaks down fat and handles insulin. GIP specifically targets white adipose tissue, making tirzepatide a more potent metabolic regulator.
Side Effects and Tolerability
Because both drugs alter gastric motility, their side effect profiles are similar. Common to both: nausea, constipation or diarrhea, fatigue, and acid reflux.
Interestingly, despite driving more rapid weight loss, tirzepatide is often reported by clinicians to be better tolerated than semaglutide. The GIP component appears to possess anti-emetic properties, helping offset the severe nausea often caused by GLP-1 activation.
Patients who "fail" semaglutide due to severe nausea are frequently transitioned to tirzepatide with better success.
Cardiovascular and Long-Term Safety
This is where semaglutide currently holds the advantage. The landmark SELECT trial proved that semaglutide reduces the risk of major adverse cardiovascular events by 20% in high-risk patients.
Tirzepatide is newer. While early data strongly suggests it is cardioprotective, its massive cardiovascular outcome trials (SURPASS-CVOT) are still concluding.
Cost and Accessibility
Branded versions of both exceed $1,000/month without insurance. Through compounding pharmacies:
- Compounded Semaglutide: $200-350/month
- Compounded Tirzepatide: $350-500+/month
How to Choose
Choose Semaglutide if: you have less than 30 pounds to lose, have cardiovascular disease history and want the most proven heart data, or budget is your primary constraint.
Choose Tirzepatide if: you have significant weight to lose (BMI > 30), have severe metabolic syndrome or insulin resistance, or previously tried semaglutide and either plateaued or couldn't tolerate the nausea.